Ohio Board Of Pharmacy Recommends Ban On Kratom

LONDON - AUGUST 26:  Homeopathic remedies are seen at Ainsworths Pharmacy on August 26, 2005 in London. British medical journal The Lancet has attacked the use of homeopathic treatments saying that doctors should be honest about homeopathy's lack of benefit. A joint UK/Swiss survey of 110 trials found no convincing evidence that homeopathy worked any better than a placebo.  (Photo by Peter Macdiarmid/Getty Images)

WASHINGTON, — Dave Herman, Chairman of the American Kratom Association, strongly denounced the action by the State Board of Pharmacy on October 1, 2018, to commence the process to schedule kratom as a Schedule I controlled substance in Ohio.

“The findings of the Ohio Board of Pharmacy today parrot the false propaganda of the US Food and Drug Administration (FDA) in their crusade to ban kratom. The FDA attempted the same scheduling process in 2016, and that recommendation was rejected by the Drug Enforcement Administration (DEA) because the FDA data failed to meet the required standards for the scheduling of kratom at the federal level,” Herman stated.

“Since their failure in 2016, the FDA has launched a broad-based campaign to demonize this natural plant by consistently misstating the science and the actual pharmacologic activity of kratom,” continued Herman. “The FDA has flooded state regulators, including the Ohio Board of Pharmacy with false claims and disinformation about the addiction profile and safety of this safe botanical plant.”

The FDA Commissioner, Scott Gottlieb, has repeatedly stated that kratom is an opioid, but credible scientists strongly dispute that statement showing that kratom’s pharmacologic activity is distinctly different than classic opioids where the respiratory system of the user shuts down and leads to overdoses that have created the opioid crisis that we are in today.

Continue Reading at Biospace

Ohio Board Of Pharma
Do Drug Addicts Real
Rate This Article: